HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isao Nagaoka Selected Research

Glucosamine (Dona)

7/2020Citrulline cooperatively exerts an anti-inflammatory effect on synovial cells with glucosamine and N-acetylglucosamine.
7/2019Chondroprotective action of glucosamine, a chitosan monomer, on the joint health of athletes.
3/2013Evaluation of the effect of glucosamine administration on biomarkers of cartilage and bone metabolism in bicycle racers.
10/2012Evaluation of the effect of methionine and glucosamine on adjuvant arthritis in rats.
3/2012Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study.
1/2012Biological activities of glucosamine and its related substances.
9/2011Effect of glucosamine, a therapeutic agent for osteoarthritis, on osteoblastic cell differentiation.
9/2011Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study.
6/2011Effects of glucosamine derivatives and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes.
3/2010Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isao Nagaoka Research Topics

Disease

23Sepsis (Septicemia)
05/2021 - 01/2005
19Inflammation (Inflammations)
01/2021 - 04/2002
17Neoplasms (Cancer)
09/2019 - 02/2006
14Colorectal Neoplasms (Colorectal Cancer)
09/2019 - 12/2002
14Osteoarthritis
07/2019 - 04/2002
9Septic Shock (Toxic Shock Syndrome)
06/2017 - 09/2002
8Knee Osteoarthritis
11/2017 - 09/2010
8Infections
02/2016 - 03/2004
4Disseminated Intravascular Coagulation
01/2021 - 05/2013
4Pain (Aches)
07/2017 - 09/2010
4Arthritis (Polyarthritis)
04/2017 - 04/2002
4Atherosclerosis
01/2011 - 07/2004
4Skin Diseases (Skin Disease)
01/2009 - 08/2005
3Bacterial Infections (Bacterial Infection)
05/2021 - 01/2002
3Glioblastoma (Glioblastoma Multiforme)
01/2020 - 03/2017
3Astrocytoma (Pilocytic Astrocytoma)
01/2020 - 03/2017
3Necrosis
04/2016 - 03/2004
3Acute Lung Injury
07/2014 - 08/2011
3Pneumonia (Pneumonitis)
07/2014 - 09/2003
3Bone Resorption
03/2013 - 02/2011
3Wounds and Injuries (Trauma)
06/2012 - 01/2006
3Synovitis
05/2012 - 02/2011
3Acute Promyelocytic Leukemia
12/2007 - 02/2006
2Mycoses (Diseases, Fungus)
05/2021 - 04/2009
2Joint Diseases (Joint Disease)
07/2020 - 06/2011
2type 2C Congenital disorder of glycosylation
12/2018 - 04/2010
2Osteoporosis
01/2018 - 05/2015
2Disease Progression
11/2017 - 08/2011
2Leukemia
01/2017 - 08/2002
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2014 - 08/2011
2Body Weight (Weight, Body)
10/2012 - 03/2011
2Reperfusion Injury
04/2010 - 12/2005
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2008 - 08/2008
2Rupture
02/2008 - 12/2006
1Endotoxemia
05/2021

Drug/Important Bio-Agent (IBA)

14Glucosamine (Dona)IBA
07/2020 - 04/2002
12Fluorouracil (Carac)FDA LinkGeneric
09/2019 - 06/2006
10Biomarkers (Surrogate Marker)IBA
05/2021 - 03/2010
10CytokinesIBA
08/2020 - 01/2002
10CollagenIBA
04/2019 - 12/2005
10Peptides (Polypeptides)IBA
06/2017 - 09/2002
9Collagen Type II (Type II Collagen)IBA
07/2019 - 03/2010
8Pharmaceutical PreparationsIBA
05/2021 - 01/2007
8LipopolysaccharidesIBA
08/2020 - 01/2005
7EndotoxinsIBA
05/2021 - 01/2005
7AntithrombinsIBA
12/2020 - 05/2013
7CathelicidinsIBA
10/2020 - 09/2002
6Interleukin-6 (Interleukin 6)IBA
07/2020 - 07/2008
6Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2019 - 03/2010
6Leucovorin (Folinic Acid)FDA Link
02/2019 - 03/2010
6Hyaluronic Acid (Hyaluronan)IBA
10/2012 - 09/2010
5Irinotecan (Camptosar)FDA LinkGeneric
02/2019 - 03/2010
5HMGB1 Protein (HMG1)IBA
06/2017 - 03/2009
4Dacarbazine (DIC)FDA LinkGeneric
01/2021 - 05/2013
4Biological ProductsIBA
08/2020 - 02/2008
4AcetylglucosamineIBA
07/2020 - 09/2016
4Interleukin-8 (Interleukin 8)IBA
01/2020 - 08/2008
4ChemokinesIBA
06/2017 - 03/2007
4IronIBA
11/2014 - 04/2008
4EnzymesIBA
06/2011 - 06/2006
4Proteins (Proteins, Gene)FDA Link
01/2011 - 10/2006
3Proteoglycans (Proteoglycan)IBA
07/2017 - 03/2010
3ThrombomodulinIBA
06/2017 - 04/2014
3Matrix Metalloproteinases (MMPs)IBA
06/2017 - 12/2006
3Histones (Histone)IBA
12/2015 - 01/2013
3GalactosamineIBA
03/2011 - 08/2009
3MacrolidesIBA
03/2009 - 07/2002
3TransferasesIBA
07/2006 - 12/2002
2InterleukinsIBA
01/2020 - 11/2017
2Substance PIBA
01/2020 - 03/2017
2FlavonoidsIBA
01/2019 - 01/2011
2Teriparatide (Parathar)FDA Link
01/2018 - 05/2015
2Paclitaxel (Taxol)FDA LinkGeneric
09/2017 - 07/2017
2Tolonium ChlorideFDA Link
06/2017 - 03/2010
2DNA (Deoxyribonucleic Acid)IBA
07/2014 - 01/2013
2Pathogen-Associated Molecular Pattern MoleculesIBA
01/2014 - 01/2014
2AnticoagulantsIBA
01/2014 - 05/2013
2ProstaglandinsIBA
10/2012 - 09/2003
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
03/2012 - 09/2011
2AntioxidantsIBA
09/2011 - 01/2011
2LipidsIBA
03/2011 - 01/2011
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2008 - 09/2003
2promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
12/2007 - 10/2006
2beta-DefensinsIBA
03/2007 - 01/2002
2Anti-Bacterial Agents (Antibiotics)IBA
01/2006 - 11/2005
2Superoxides (Superoxide)IBA
07/2004 - 08/2002
2Chemotactic FactorsIBA
03/2004 - 04/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2004 - 09/2002
1GlucansIBA
05/2021
1ThrombinFDA Link
01/2021
1Anti-Infective Agents (Microbicides)IBA
08/2020
1CitrullineIBA
07/2020

Therapy/Procedure

11Therapeutics
01/2021 - 01/2009
8Drug Therapy (Chemotherapy)
09/2019 - 03/2010
3Oral Administration
10/2017 - 06/2017
2Punctures
10/2020 - 01/2016
2Ligation
10/2020 - 01/2016
2Intravenous Infusions
07/2014 - 04/2014
2Esophagectomy
07/2014 - 08/2011
2Adjuvant Chemotherapy
07/2006 - 06/2006